Paul T. Quinlan, General Counsel: Oruka Therapeutics ORKA Sell · Filed 03/17

Trade details

Type: Insider sale
Amount: $30,272.9
Shares · price: 733 sh · $41.30 a share
Held after: 31,767 sh
Stock: Oruka Therapeutics ORKA
Person: Paul T. QuinlanGeneral Counsel
Trade date: 26/03/16
Filed: 26/03/17
Days to filing: 1 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Oruka Therapeutics trades, last 26 weeks

What else happened in Oruka Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Paul T. Quinlan's recent trades

Paul T. QuinlanGeneral Counsel
Planned sale10b5-1 planOruka Therapeutics
Planned sale10b5-1 plan
Oruka Therapeutics
ORKA
$7.7M
71,000 sh
$7.7M
Filed 08/14
Traded 08/14
Paul T. QuinlanGeneral Counsel
SellOruka Therapeutics
Sell
Oruka Therapeutics
ORKA
$51.1K
733 sh
$51.1K
Filed 06/15
Traded 06/15
Paul T. QuinlanGeneral Counsel
SellCymaBay Therapeutics
Sell
CymaBay Therapeutics
CBAY
$117.9K
5,000 sh
$117.9K
Filed 24/01/16
Traded 24/01/16
Paul T. QuinlanGeneral Counsel
SellCymaBay Therapeutics
Sell
CymaBay Therapeutics
CBAY
$109.9K
5,000 sh
$109.9K
Filed 23/12/15
Traded 23/12/15
Paul T. QuinlanGeneral Counsel
SellCymaBay Therapeutics
Sell
CymaBay Therapeutics
CBAY
$86.9K
5,000 sh
$86.9K
Filed 23/11/17
Traded 23/11/15